GUARDANT HEALTH, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $381.37M.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $0.00.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for fiscal 2025 was $239.46M.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for fiscal 2023 was $381.37M.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for fiscal 2020 was $354.60M, a 1.40% increase from fiscal 2019.
- GUARDANT HEALTH, INC. stock issued during period, value, new issues for fiscal 2019 was $349.71M, a 40.15% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $239.46M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $381.37M 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2023-06-30 | $381.37M 10-Q · filed 2024-08-07 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $354.60M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $354.60M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $349.71M 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | |
| 2019-06-30 | $349.71M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $249.53M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |